Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Meyer

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Medical Cannabis and Cannabinoids|October 22, 2021
Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD FormulationsPascale Meyer, Manuela Langos, Rudolf Brenneisen
Analytical and Bioanalytical Chemistry|January 30, 2010
Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletesRudolf Brenneisen, Pascale Meyer, Haithem Chtioui, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Medical Cannabis and Cannabinoids|October 22, 2021
Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD FormulationsPascale Meyer, Manuela Langos, Rudolf Brenneisen
Analytical and Bioanalytical Chemistry|January 30, 2010
Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletesRudolf Brenneisen, Pascale Meyer, Haithem Chtioui, et al.
Pageof 1